| How much does it cost to research and develop a new drug? A systematic review and assessment M Schlander, K Hernandez-Villafuerte, CY Cheng, J Mestre-Ferrandiz, ... Pharmacoeconomics 39, 1243-1269, 2021 | 189 | 2021 |
| Mapping priority setting in health in 17 countries across Asia, Latin America, and sub-Saharan Africa R Li, K Hernandez-Villafuerte, A Towse, I Vlad, K Chalkidou Health Systems & Reform 2 (1), 71-83, 2016 | 53 | 2016 |
| Economic evaluation of meningococcal vaccines: considerations for the future H Christensen, H Al-Janabi, P Levy, MJ Postma, DE Bloom, P Landa, ... The European Journal of Health Economics 21, 297-309, 2020 | 37 | 2020 |
| Bibliometric trends of health economic evaluation in Sub-Saharan Africa K Hernandez-Villafuerte, R Li, KJ Hofman Globalization and Health 12, 1-15, 2016 | 32 | 2016 |
| Cost‐effectiveness of risk‐based breast cancer screening: a systematic review SA Khan, KV Hernandez‐Villafuerte, MT Muchadeyi, M Schlander International journal of cancer 149 (4), 790-810, 2021 | 23 | 2021 |
| Economies of scale and scope in publicly funded biomedical and health research: evidence from the literature K Hernandez-Villafuerte, J Sussex, E Robin, S Guthrie, S Wooding Health Research Policy and Systems 15, 1-17, 2017 | 23 | 2017 |
| Challenges and methodologies in using progression free survival as a surrogate for overall survival in oncology K Hernandez-Villafuerte, A Fischer, N Latimer International Journal of Technology Assessment in Health Care 34 (3), 300-316, 2018 | 17 | 2018 |
| Kosten der Onkologie in Deutschland M Schlander, K Hernandez-Villafuerte, C Thielscher Forum 33 (5), 330-337, 2018 | 14 | 2018 |
| The value of international volunteers experience to the NHS B Zamora, M Gurupira, M Rodes Sanchez, Y Feng, ... Globalization and Health 15, 1-12, 2019 | 12 | 2019 |
| Government and charity funding of cancer research: public preferences and choices KK Shah, J Sussex, K Hernandez-Villafuerte Health research policy and systems 13, 1-14, 2015 | 12 | 2015 |
| Do NICE decisions affect decisions in other countries? K Hernández-Villafuerte, M Garau, N Devlin Value in Health 17 (7), A418, 2014 | 10 | 2014 |
| The relationship between spatial price transmission and geographical distance: the case of Brazil KV Hernandez-Villafuerte | 10 | 2010 |
| Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany D Hernandez, C Cheng, K Hernandez-Villafuerte, M Schlander Oncology Research 30 (4), 173, 2022 | 9 | 2022 |
| Issues surrounding the estimation of the opportunity cost of adopting a new health care technology: areas for further research K Hernandez-Villafuerte, B Zamora, A Towse London: Office of Health Economics, 2018 | 8 | 2018 |
| International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa K Hernandez-Villafuerte, R Li, A Towse, K Chalkidou Occasional Papers, 2015 | 8 | 2015 |
| Exploring the Interdependencies of Research Funders in the UK K Shah, J Sussex, K Hernandez-Villafuerte, M Garau, D Rotolo, ... Available at SSRN 2644302, 2014 | 8 | 2014 |
| Improving efficiency and resource allocation in future cancer care A Cole, A Lundqvist, P Lorgelly, H Norrlid, S Karlsberg Schaffer, F Lewis, ... Consulting Reports, 2016 | 7 | 2016 |
| The expanding value footprint of oncology treatments JC Rejón-Parrilla, K Hernández-Villafuerte, K Shah, J Mestre-Ferrandiz, ... Value in Health 17 (7), A654, 2014 | 7 | 2014 |
| The relationship between spatial integration and geographical distance in Brazil K Hernandez-Villafuerte Annual Meeting of the European Association of Agricultural Economics (EAAE …, 2011 | 7 | 2011 |
| Economic burden of pancreatic cancer in Europe: a literature review D Hernandez, F Wagner, K Hernandez-Villafuerte, M Schlander Journal of Gastrointestinal Cancer 54 (2), 391-407, 2023 | 6 | 2023 |
